Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation

Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation

Background Hepatoblastoma (HB) is a rare malignancy usually occurring in children under 3 years old. With advancements in surgical techniques and molecular biology, new treatments have been developed.Data resources The recent literatures on new treatments, molecular mechanisms and clinical trials fo...

Full description

Bibliographic Details
Main Authors:	Rui Dong, Zhixue Chen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-07-01
Series:	World Journal of Pediatric Surgery
Online Access:	https://wjps.bmj.com/content/4/3/e000220.full

Similar Items

Research advances in diagnosis and treatment of adult hepatoblastoma
by: YANG Jie
Published: (2015-02-01)

Hepatoblastoma
by: Raùl Pichardo-Bahena, et al.
Published: (2005-04-01)

Guidelines for the diagnosis and treatment of hepatoblastoma (2019)
by: Compilation and Examination Expert Group for Guidelines for the diagnosis and treatment of hepatoblastoma (2019)
Published: (2019-11-01)

Adult hepatoblastoma
by: Javier A. Cienfuegos, et al.

The Genetic Changes of Hepatoblastoma
by: Huitong Chen, et al.
Published: (2021-07-01)

Hepatoblastoma: when to screen?
by: O’Malley Margaret, et al.
Published: (2011-03-01)

Hepatoblastoma with precocious puberty
by: Enono Yhoshu, et al.
Published: (2019-01-01)

Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
by: Rui Sun, et al.
Published: (2021-04-01)

A case of giant hepatoblastoma
by: MA Linjie, et al.
Published: (2016-11-01)

Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma
by: Bai-Hui Liu, et al.
Published: (2018-01-01)

UPDATES ON THE DIAGNOSIS AND TREATMENT OF PEDIATRIC HEPATOBLASTOMA WITH PULMONARY METASTASES
by: Oana Tatiana Miron, et al.
Published: (2016-03-01)

Prenatal Diagnosis of Congenital Hepatoblastoma
by: Jia-Yan Wang, et al.
Published: (2020-04-01)

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
by: Sarah E. Woodfield, et al.
Published: (2021-02-01)

Clinical characteristics and survival of children with hepatoblastoma: Single centre experience
by: Krstovski Nada, et al.
Published: (2008-01-01)

Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
by: Jia-Feng Wu, et al.
Published: (2017-08-01)

Hepatoblastomas in Oman : Unveiling success
by: Fatma Rabah, et al.
Published: (2015-02-01)

Hepatoblastomas in Oman: Unveiling success
by: Fatma Rabah, et al.
Published: (2015-01-01)

Mesenchymal Hamartoma Mimicking Hepatoblastoma
by: A Bahador, et al.
Published: (2014-05-01)

Hepatoblastoma associated with trisomy 18
by: Naruhiko Murase, et al.
Published: (2020-01-01)

Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)

The Role of BH3-Mimetic Drugs in the Treatment of Pediatric Hepatoblastoma
by: Justus Lieber, et al.
Published: (2015-02-01)

Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
by: Wei-Yun Hsu, et al.
Published: (2020-08-01)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
by: Junting Huang, et al.
Published: (2020-11-01)

Hepatoblastoma: current understanding, recent advances, and controversies [version 1; referees: 3 approved]
by: Piotr Czauderna, et al.
Published: (2018-01-01)

Genetic Profile and Clinical Implications of Hepatoblastoma and Neuroblastoma Coexistence in a Child
by: Szymon Skoczen, et al.
Published: (2019-04-01)

Clinical and Pathological Study of Tumor Border Invasion—Is Narrow Resection Margin Acceptable in Hepatoblastoma Surgery?
by: Gang Shen, et al.
Published: (2020-03-01)

The Role of MicroRNAs in Hepatoblastoma Tumors
by: Ion Cristóbal, et al.
Published: (2019-03-01)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
by: Jose J. G. Marin, et al.
Published: (2019-03-01)

Hepatoblastoma in the neonatal period: An unusual presentation
by: Sarbani Chattopadhyay, et al.
Published: (2012-01-01)

Genetic and epigenetic basis of hepatoblastoma diversity
by: Genta Nagae, et al.
Published: (2021-09-01)

Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
by: Irene Isabel P. Lim, et al.
Published: (2018-12-01)

Extrahepatic hepatoblastoma- an extremely rare occurrence
by: Y.K. Sarin, et al.
Published: (2021-04-01)

Hepatoblastoma: Analysis of treatment outcome from a tertiary care center
by: Sanju Cyriac, et al.
Published: (2011-01-01)

The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials
by: Daniel C Aronson, et al.
Published: (2014-01-01)

Treatment Outcomes for Hepatoblastoma: Experience of 35 Cases at a Single Institution
by: Pei-Kwei Tsay, et al.
Published: (2011-05-01)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
by: Sarah E. Woodfield, et al.
Published: (2021-10-01)

Genotypic Characteristics of Hepatoblastoma as Detected by Next Generation Sequencing and Their Correlation With Clinical Efficacy
by: Huimin Hu, et al.
Published: (2021-08-01)

Clinical experience and outcome of hepatoblastoma in children: A 9-year retrospective study
by: Sanjeev Khera, et al.
Published: (2016-01-01)

Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system
by: Carlos A. Leal-Leal, et al.
Published: (2010-01-01)

Successfully Surgical Treatment of Lung Metastatic Hepatoblastoma: A Rare Case Report
by: Halim Bardi Taneh, et al.
Published: (2017-08-01)